The first step is to measure cardiovascular risk more accurately, think in cumulative exposure rather than only 10-year horizons, use apoB where possible and especially where standard markers are most likely to underrepresent risk, intervene earlier when trajectory, family history, metabolic phenotype, or imaging suggest that the risk is being understated, and keep treatment burden proportional to the quality of evidence and the person in front of the doctor
Copper (II) chloride, 99%, and copper (II) acetate monohydrate, ACS reagent, 98%, powder were purchased from Sigma-Aldrich (St
2 A healthy follicle is embedded in a well-organized dermal niche, and remodeling that niche could, in principle, create a more hospitable environment for follicular function
Evidence remains largely preclinical, with growing interest in translational applications for aging, metabolic disorders, and neurodegeneration
Neuron 52 : 817830